Search

everythinglearnresearchcommunity

for

Search:↓

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Finasteride, selenium, and vitamin E may help prevent prostate cancer.

Alopecia treatments like 5α-reductase inhibitors and spironolactone are safe for breast cancer patients and high-risk women.

The combination therapy effectively treats infertility in PCOS without major side effects.

Diphenyl ethers can potentially reduce excess oil production when applied on the skin, helping treat conditions like acne.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

Goserelin and oestradiol treatment slightly improved hairiness but did not significantly change sebum production or hair characteristics in mildly hirsute women.

Hair loss in women can be treated with hormone therapy.

α-Blockers and 5-ARIs for BPH can cause sexual dysfunction, including erectile and ejaculatory issues.

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

5α-reductase inhibitors don't stop bladder cancer from developing or getting worse.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Spironolactone does not increase the risk of breast cancer recurrence.

Cyproterone acetate therapy improved hair loss and reduced testosterone levels in a menopausal woman.

Some birth control pills have a higher risk of blood clots than others.

Spironolactone most effective for hirsutism, but has side effects.

Spironolactone helps prevent swelling caused by minoxidil in women with hair loss.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

Sex hormones might influence bladder cancer development, and aromatase inhibitors could increase risk in postmenopausal women.

Some drugs can cause hair loss, and stopping these drugs often leads to hair regrowth.

Some cannabinoid derivatives may be more effective than current drugs at targeting proteins relevant to prostate cancer treatment.

Many drugs, not just chemotherapy, can cause reversible hair loss.

Spironolactone may make some cancer treatments more effective by blocking a protein that helps cancer cells survive.

Epristeride's metabolism involves key metabolites and proteins, affecting its use in doping tests.

Compounds 6f and 6g effectively stop prostate cancer cell growth without harming healthy cells.

Antiandrogens help manage PCOS symptoms but need careful monitoring.

Spironolactone effectively treats female pattern hair loss but requires ongoing use to maintain results.

The traditional herbal formulas Yongdamsagan-Tang and Paljung-san, along with the drug finasteride, can reduce inflammation and may work together without affecting each other's effectiveness against benign prostatic hyperplasia.